Scientific publications

Scientific Publication
12.11.2018

American Association for the Study of Liver Diseases (AASLD), 2018 Congress – TOTUM-63 reduces hepatic steatosis

View
Scientific Publication
04.10.2018

European Association for the Study of Diabetes (EASD), 2018 Congress, Berlin (Germany) – TOTUM-63 multi-target mode of action

View
Scientific Publication
07.03.2018

Keystone Symposia 2018, Banff (Canada) – LpD64 reduces intestinal dysbiosis associated with metabolic disorders

View
Scientific Publication
03.03.2018

Keystone Symposia 2018, Keystone (USA) – TOTUM-63 acts on intestinal microbiota

View
Scientific Publication
04.12.2017

International Diabetes Federation, 2017 Congress, Abu Dhabi (UAE) – TOTUM-63 reduces hepatic steatosis

View
Scientific Publication
06.06.2018

Cell Symposium 2017, San Diego (USA) – LpD64, in vivo effects on lipids metabolism

View
Scientific Publication
02.08.2017

American Diabetes Association, 2017 Congress, San Diego (USA) – VALEDIA®, results of the Phase I/II clinical study

View
Scientific Publication
16.03.2017

Société Francophone du Diabète, 2017 Congress, Lille (France) – TOTUM-63, preclinical data on insulin resistance and fat mass

View
Scientific Publication
10.06.2018

American Diabetes Association, 2016 Congress, New Orleans (USA) – TOTUM-63, preclinical data on glucose metabolism

View